Scolaris Content Display Scolaris Content Display

Physical interventions for breathlessness in adults with advanced diseases

Esta versión no es la más reciente

Referencias

Additional references

Ameer 2014

Ameer F, Carson KV, Usmani ZA, Smith BJ. Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest. Cochrane Database of Systematic Reviews 2014, Issue 6. [DOI: 10.1002/14651858.CD000238.pub2]

AUREF 2012

Cochrane Pain, Palliative and Supportive Care Group. PaPaS author and referee guidance. papas.cochrane.org/papas‐documents (accessed 6 July 2016).

Bailey 2010

Bailey CD, Wagland R, Dabbour R, Caress A, Smith J, Molassiotis A. An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses. BMC Pulmonary Medicine 2010;10(63):1‐13. [DOI: 10.1186/1471‐2466‐10‐63]

Barnes 2016

Barnes H, McDonald J, Smallwood N, Manser R. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database of Systematic Reviews 2016, Issue 3. [DOI: 10.1002/14651858.CD011008.pub2]

Barst 2004

Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. Journal of the American College of Cardiology 2004;43(12):40‐7. [DOI: 10.1016/j.jacc.2004.02.032]

Bernard 1999

Bernard S, Whittom F, LeBlanc P, Jobin J, Belleau R, Berube C, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1999;159(3):896‐901.

Bolton 2013

Bolton CE, Bevan‐Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax 2013;68(Suppl 2):ii1‐ii30. [10.1136/thoraxjnl‐2013‐203808]

Booth 2008

Booth S, Moosavi SH, Higginson IJ. The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. Nature Clinical Practice Oncology 2008;5(2):90‐100. [DOI: 10.1038/ncponc1034]

Booth 2011

Booth S, Moffat C, Burkin J, Galbraith S, Bausewein C. Nonpharmacological interventions for breathlessness. Current Opinion in Supportive and Palliative Care 2011;5(2):77‐86.

Booth 2014

Booth S, Burkin J, Moffat C, Spathis A. Managing Breathlessness in Clinical Practice. London: Springer‐Verlag, 2014:396‐8. [DOI: 10.1007/978‐1‐4471‐4754‐1; ISBN 978‐1‐4471‐4754‐1]

Bourjeily‐Habr 2002

Bourjeily‐Habr G, Rochester CL, Palermo F, Snyder P, Mohsenin V. Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax 2002;57(12):1045‐9. [DOI: 10.1136/thorax.57.12.1045]

Breaden 2011

Breaden K. Recent advances in the management of breathlessness. Indian Journal of Palliative Care 2011;17:29‐32. [PUBMED: 3140084]

Burtin 2012

Burtin C, Saey D, Saglam M, Langer D, Gosselink R, Janssens W, et al. Effectiveness of exercise training in patients with COPD: the role of muscle fatigue. European Respiratory Journal 2012;40(2):338‐44.

Chin 2016

Chin C, Booth S. Managing breathlessness: a palliative care approach. Postgraduate Medical Journal April 2016;92:393‐400. [DOI: 10.1136/postgradmedj‐2015‐133578]

Cranston 2008

Cranston JM, Crockett A, Currow D. Oxygen therapy for dyspnoea in adults. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD004769.pub2]

Ferreira 2012

Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD000998.pub3]

GRADEpro GDT 2015 [Computer program]

GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 01 July 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2015.

Graham 2010

Graham L. ACCP releases statement on dyspnea treatment in patients with advanced lung or heart disease. American Family Physician 2010;82(8):999‐1000.

Guz 1997

Guz A. Brain, breathing and breathlessness. Respiration Physiology 1997;109(3):197–204.

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. Available from www.cochrane‐handbook.org. The Cochrane Collaboration.

Johnson 2014

Johnson MJ, Currow DC, Booth S. Prevalence and assessment of breathlessness in the clinical setting. Expert Review of Respiratory Medicine 2014;8(2):151‐61. [DOI: 10.1586/17476348.2014.879530]

Jones 2016

Jones S, Man WDC, GaoW, Higginson IJ, Wilcock A, Maddocks M. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database of Systematic Reviews 2016, Issue 10. [DOI: 10.1002/14651858.CD009419.pub3]

Lansing 2009

Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respiratory Physiology & Neurobiology 2009;167(1):53‐60. [DOI: 10.1016/j.resp.2008.07.012]

Maddocks 2016

Maddocks M, Nolan CM, Man WDC, Polkey MI, Hart N, Gao W, et al. Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD: a randomised double‐blind, placebo‐controlled trial. Lancet Respiratory Medicine 2016;4(1):27‐36. [DOI: http://dx.doi.org/10.1016/S2213‐2600(15)00503‐2]

Mahler 2013

Mahler DA. Opioids for refractory dyspnea. Expert Review of Respiratory Medicine 2013;7(2):123‐35. [DOI: 10.1586/ers.13.5]

McCarthy 2015

McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2015, Issue 2. [DOI: 10.1002/14651858.CD003793.pub3]

Meek 1999

Meek PM, Schwartzstein RM, Adams L, Altose MD, Breslin EH, Carrieri‐Kohlman V, et al. Dyspnea mechanisms, assessment, and management: a consensus statement. American Journal of Respiratory and Critical Care Medicine 1999;159(1):321–40. [DOI: 10.1164/ajrccm.159.1.ats898]

Moens 2014

Moens K, Higginson IJ, Harding R. Are there differences in the prevalence of palliative care‐related problems in people living with advanced cancer and eight non‐cancer conditions? A systematic review. Journal of Pain and Symptom Management 2014;48(4):660‐77. [DOI: 10.1016/j.jpainsymman.2013.11.009]

Moher 2009

Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097.

Neder 2002

Neder JA, Sword D, Ward SA, Mackay E, Cochrane LM, Clark CJ. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 2002;57(4):333‐7.

Netter 2012

Kaminsky DA. The Netter Collection of Medical Illustrations – Respiratory System. 2nd Edition. Vol. 3, Munich: Urban & Fischer, 2012. [DOI: 10.1016/B978‐3‐437‐41792‐4.02001‐6; ISBN 978‐1‐4377‐0574‐4]

O'Shea 2007

O'Shea SD, Taylor NF, Paratz JD. Qualitative outcomes of progressive resistance exercise for people with COPD. Chronic Respiratory Disease 2007;4(3):135‐42.

Ortega 2002

Ortega F, Toral J, Cejudo P, Villagomez R, Sánchez H, Castillo J, et al. Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2002;166(5):669‐74. [DOI: 10.1164/rccm.2107081]

Parshall 2012

Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society Statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine 2012;185(4):435–52. [DOI: 10.1164/rccm.201111‐2042ST]

RevMan 2014 [Computer program]

Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Rochester 2015

Rochester Cl, Vogiatzis I, Holland AE, Lareau SC, Marciniuk DD, Puhan MA, et al. An official American Thoracic Society/European Respiratory Society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine 2015;192(11):1373‐86. [10.1164/rccm.201510‐1966ST]

Rohwer 2017

Rohwer A, Booth A, Pfadenhauer L, Burns J, Brereton L, Gerhardus A, et al. Logic models help make sense of complexity in systematic reviews and health technology assessments. Journal of Clinical Epidemiology 2017;83:37‐47.

Sharp 2016

Sharp C, Adamali H, Millar AB. Ambulatory and short‐burst oxygen for interstitial lung disease. Cochrane Database of Systematic Reviews 2016, Issue 7. [DOI: 10.1002/14651858.CD011716.pub2]

Simon 2016

Simon ST, Higginson IJ, Booth S, Harding R, Weingärtner V, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non‐malignant diseases in adults. Cochrane Database of Systematic Reviews 2016, Issue 10. [DOI: 10.1002/14651858.CD007354.pub3]

Solano 2006

Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. Journal of Pain and Symptom Management 2006;31(1):58–69. [DOI: 10.1016/j.jpainsymman.2005.06.007]

Solway 2001

Solway SB. The short‐term effect of a rollator on functional exercise capacity in individuals with severe chronic obstructive pulmonary disease. tspace.library.utoronto.ca/bitstream/1807/15404/1/MQ58885.pdf 2001 (accessed 30th Aug 2016). [called up: 01.04.2016]

Spathis 2017

Spathis A, Booth S, Moffat C, Hurst R, Ryan R, Chin C, Burkin J. The Breathing, Thinking, Functioning clinical model: a proposal to facilitate evidence‐based breathlessness management in chronic respiratory disease. Primary Care Respiratory Medicine 2017;27. [DOI: 10.1038/s41533‐017‐0024‐z]

Teunissen 2007

Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: a systematic review. Journal of Pain and Symptom Management 2007;34(1):94‐104. [DOI: 10.1016/j.jpainsymman.2006.10.015]

Vieira 2014

Vieira PJC, Chiappa AMG, Cipriano G, Umpierre D, Arena R, Chiappa GR. Neuromuscular electrical stimulation improves clinical and physiological function in COPD patients. Respiratory Medicine 2014;108(4):609‐20. [DOI: http://dx.doi.org/10.1016/j.rmed.2013.12.013]

Vivodtzev 2012

Vivodtzev I, Debigaré R, Gagnon P, Mainguy V, Saey D, Dubé A, et al. Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial. CHEST Journal 2012;141(3):716‐25. [DOI: 10.1378/chest.11‐0839]

References to other published versions of this review

Bausewein 2008

Bausewein C, Booth S, Gysels M, Higginson IJ. Non‐pharmacological interventions for breathlessness in advanced stages of malignant and non‐malignant diseases. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD005623.pub2; Art.No.:CD005623]

Perpetuation of breathlessness by vicious cycles (Booth 2014)
Figuras y tablas -
Figure 1

Perpetuation of breathlessness by vicious cycles (Booth 2014)

System‐based logic model on physical interventions for breathlessness in patients with advanced diseases
Figuras y tablas -
Figure 2

System‐based logic model on physical interventions for breathlessness in patients with advanced diseases